← Back to Search

Reading Tutoring for Executive Function Development in Children

N/A
Recruiting
Led By Laurie E Cutting, PhD
Research Sponsored by Vanderbilt University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children in Kindergarten (approximate ages 4-9 years)
Native English speakers
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 1 year after baseline (fall of 1st grade); and approximately 1 year 3 months after baseline (spring of 1st grade)
Awards & highlights

Study Summary

This trial will study how well reading, math, and executive function skills interact in young children's brains to predict academic outcomes.

Who is the study for?
This trial is for Kindergarten children, approximately ages 4-9, who are native English speakers. It's not suitable for kids with intellectual disabilities, uncorrectable vision or significant hearing loss, metal devices that preclude MRI scans, IQ below 70, neurological issues like epilepsy or brain tumors, severe psychiatric disorders or those on certain psychotropic meds.Check my eligibility
What is being tested?
The study examines how brain networks related to reading skills and executive functions (EF) interact in young children. By following participants from Kindergarten through 1st grade, the research aims to predict academic outcomes and see how well they respond to reading tutoring interventions.See study design
What are the potential side effects?
Since this trial involves educational interventions such as reading tutoring rather than medical treatments or drugs, there are no direct physical side effects expected. However, participation may involve time commitment and potential stress associated with testing environments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is in Kindergarten, aged between 4-9 years.
Select...
I am a native English speaker.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 1 year after baseline (fall of 1st grade); and approximately 1 year 3 months after baseline (spring of 1st grade)
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 1 year after baseline (fall of 1st grade); and approximately 1 year 3 months after baseline (spring of 1st grade) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Woodcock Johnson Tests of Achievement, Fourth Edition (WJ-IV)
Woodcock Johnson Tests of Achievement, Fourth Edition (WJ-IV)

Trial Design

2Treatment groups
Active Control
Group I: Reading Tutoring InterventionActive Control1 Intervention
20 hours of one-on-one reading tutoring administered over 6 weeks
Group II: Business as UsualActive Control1 Intervention
Instruction as usual within schools

Find a Location

Who is running the clinical trial?

Vanderbilt UniversityLead Sponsor
705 Previous Clinical Trials
6,143,163 Total Patients Enrolled
4 Trials studying Dyslexia
1,109 Patients Enrolled for Dyslexia
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,978 Previous Clinical Trials
2,680,093 Total Patients Enrolled
10 Trials studying Dyslexia
5,834 Patients Enrolled for Dyslexia
Laurie E Cutting, PhDPrincipal InvestigatorVanderbilt University

Media Library

Reading Tutoring Clinical Trial Eligibility Overview. Trial Name: NCT03713125 — N/A
Dyslexia Research Study Groups: Reading Tutoring Intervention, Business as Usual
Dyslexia Clinical Trial 2023: Reading Tutoring Highlights & Side Effects. Trial Name: NCT03713125 — N/A
Reading Tutoring 2023 Treatment Timeline for Medical Study. Trial Name: NCT03713125 — N/A
~0 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top